Green C J, Allison A C
Lancet. 1978 Jun 3;1(8075):1182-3. doi: 10.1016/s0140-6736(78)90970-4.
The fungal metabolite cyclosporin A has been administered daily at 25 mg/kg to nephrectomised rabbit recipients of a single renal allograft. After only 4 weeks of daily administration, rejection was prevented for long periods without the need for other immunosuppressive therapy. Renal function has been excellent in all cases, rejection episodes have not been encountered except in a small percentage of animals, and the surviving recipients are still in excellent health 3-6 months after transplantation. The possiblity that clones of responding lymphocytes might be selectively killed by this agent was suggested from earlier experiments and prompted this study. If toxicity is not encountered in man cyclosporin A may prove valuable in preventing rejection of organ and bone-marrow allografts and might be useful in treating some leukaemias of lymphoid origin.
真菌代谢产物环孢素A已以每日25毫克/千克的剂量给予接受单个同种异体肾移植的肾切除兔子。仅每日给药4周后,就长期预防了排斥反应,无需其他免疫抑制治疗。所有病例的肾功能都非常好,除了一小部分动物外,未出现排斥反应,存活的受体在移植后3至6个月仍健康状况良好。早期实验提示了这种药物可能会选择性地杀死反应性淋巴细胞克隆,从而推动了本研究。如果在人体中未发现毒性,环孢素A可能在预防器官和骨髓同种异体移植排斥方面具有重要价值,并且可能对治疗某些淋巴源性白血病有用。